Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.
Identifieur interne : 000569 ( Main/Corpus ); précédent : 000568; suivant : 000570Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.
Auteurs : D A C. Oprel ; C M Hoeboer ; M. Schoorl ; R A De Kleine ; I G Wigard ; M. Cloitre ; A. Van Minnen ; W. Van Der DoesSource :
- BMC psychiatry [ 1471-244X ] ; 2018.
English descriptors
- KwdEn :
- Adult (MeSH), Adult Survivors of Child Abuse (psychology), Female (MeSH), Humans (MeSH), Implosive Therapy (methods), Psychiatric Status Rating Scales (MeSH), Quality of Life (MeSH), Reproducibility of Results (MeSH), Stress Disorders, Post-Traumatic (etiology), Stress Disorders, Post-Traumatic (psychology), Stress Disorders, Post-Traumatic (therapy), Treatment Outcome (MeSH).
- MESH :
- etiology : Stress Disorders, Post-Traumatic.
- methods : Implosive Therapy.
- psychology : Adult Survivors of Child Abuse, Stress Disorders, Post-Traumatic.
- therapy : Stress Disorders, Post-Traumatic.
- Adult, Female, Humans, Psychiatric Status Rating Scales, Quality of Life, Reproducibility of Results, Treatment Outcome.
Abstract
BACKGROUND
Childhood abuse related posttraumatic stress disorder (CA-PTSD) is associated with a high burden of disease and with treatment response rates that leave room for improvement. One of the treatments for PTSD, prolonged exposure (PE), is effective but has high drop-out rates and remission rates are relatively low. An intensified form of PE (iPE) was associated with good response and low drop-out rates in PTSD and has not yet been tested in a controlled trial in CA-PTSD. Phase-based treatment (PBT), in which PE is preceded by skills training may improve overall outcomes in this population. We will assess the effectiveness and cost-effectiveness of standard PE, iPE and PBT in patients with CA-PTSD.
METHODS/DESIGN
Multi-center randomized controlled trial. Treatment conditions are: prolonged exposure (PE; maximum of 16 sessions in 16 weeks); intensified PE (iPE; maximum of 12 sessions in four weeks and two booster sessions); phase-based treatment (PBT; maximum of eight sessions skills training followed by eight sessions PE in 16 weeks).
PRIMARY OUTCOME
Clinician-rated PTSD symptom severity.
SECONDARY OUTCOMES
loss of PTSD diagnosis, self-reported PTSD symptom severity, comorbid symptom severity and quality of life. Moreover, we will examine cost-effectiveness and moderators and mediators of treatment outcome.
TARGET POPULATION
adults with CA-PTSD (N = 150). Assessments in weeks 0, 4, 8, 16, 26 and 52.
DISCUSSION
Given that no consensus yet exists about the treatment guidelines for patients with CA-PTSD, the present study may have important implications for the treatment of CA-PTSD.
TRAIL REGISTRATION
Registered at C.C.M.O. on Sept 7, 2016 (NL57984.058.16); retrospectively registered at June 21, 2017 at clinicaltrials.gov identifier: NCT03194113 .
DOI: 10.1186/s12888-018-1967-5
PubMed: 30541492
PubMed Central: PMC6291949
Links to Exploration step
pubmed:30541492Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.</title>
<author><name sortKey="Oprel, D A C" sort="Oprel, D A C" uniqKey="Oprel D" first="D A C" last="Oprel">D A C. Oprel</name>
<affiliation><nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hoeboer, C M" sort="Hoeboer, C M" uniqKey="Hoeboer C" first="C M" last="Hoeboer">C M Hoeboer</name>
<affiliation><nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schoorl, M" sort="Schoorl, M" uniqKey="Schoorl M" first="M" last="Schoorl">M. Schoorl</name>
<affiliation><nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="De Kleine, R A" sort="De Kleine, R A" uniqKey="De Kleine R" first="R A" last="De Kleine">R A De Kleine</name>
<affiliation><nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wigard, I G" sort="Wigard, I G" uniqKey="Wigard I" first="I G" last="Wigard">I G Wigard</name>
<affiliation><nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Clinical Psychology, University of Amsterdam, Overschiestraat 61, 1062, XD, Amsterdam, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cloitre, M" sort="Cloitre, M" uniqKey="Cloitre M" first="M" last="Cloitre">M. Cloitre</name>
<affiliation><nlm:affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>National Center for PTSD Dissemination and Training Division, Palo Alto Veterans Affairs Palo Alto Health Care System, 795 Willow Road, Menlo Park, CA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Minnen, A" sort="Van Minnen, A" uniqKey="Van Minnen A" first="A" last="Van Minnen">A. Van Minnen</name>
<affiliation><nlm:affiliation>PSYTREC, Prof. dr. Bronkhorststraat 2, 3723, MB, Bilthoven, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Radboud University, Behavioural Science Institute, Nijmegen, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Der Does, W" sort="Van Der Does, W" uniqKey="Van Der Does W" first="W" last="Van Der Does">W. Van Der Does</name>
<affiliation><nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30541492</idno>
<idno type="pmid">30541492</idno>
<idno type="doi">10.1186/s12888-018-1967-5</idno>
<idno type="pmc">PMC6291949</idno>
<idno type="wicri:Area/Main/Corpus">000569</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000569</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.</title>
<author><name sortKey="Oprel, D A C" sort="Oprel, D A C" uniqKey="Oprel D" first="D A C" last="Oprel">D A C. Oprel</name>
<affiliation><nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hoeboer, C M" sort="Hoeboer, C M" uniqKey="Hoeboer C" first="C M" last="Hoeboer">C M Hoeboer</name>
<affiliation><nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schoorl, M" sort="Schoorl, M" uniqKey="Schoorl M" first="M" last="Schoorl">M. Schoorl</name>
<affiliation><nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="De Kleine, R A" sort="De Kleine, R A" uniqKey="De Kleine R" first="R A" last="De Kleine">R A De Kleine</name>
<affiliation><nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wigard, I G" sort="Wigard, I G" uniqKey="Wigard I" first="I G" last="Wigard">I G Wigard</name>
<affiliation><nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Clinical Psychology, University of Amsterdam, Overschiestraat 61, 1062, XD, Amsterdam, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cloitre, M" sort="Cloitre, M" uniqKey="Cloitre M" first="M" last="Cloitre">M. Cloitre</name>
<affiliation><nlm:affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>National Center for PTSD Dissemination and Training Division, Palo Alto Veterans Affairs Palo Alto Health Care System, 795 Willow Road, Menlo Park, CA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Minnen, A" sort="Van Minnen, A" uniqKey="Van Minnen A" first="A" last="Van Minnen">A. Van Minnen</name>
<affiliation><nlm:affiliation>PSYTREC, Prof. dr. Bronkhorststraat 2, 3723, MB, Bilthoven, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Radboud University, Behavioural Science Institute, Nijmegen, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Der Does, W" sort="Van Der Does, W" uniqKey="Van Der Does W" first="W" last="Van Der Does">W. Van Der Does</name>
<affiliation><nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">BMC psychiatry</title>
<idno type="eISSN">1471-244X</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Adult Survivors of Child Abuse (psychology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Implosive Therapy (methods)</term>
<term>Psychiatric Status Rating Scales (MeSH)</term>
<term>Quality of Life (MeSH)</term>
<term>Reproducibility of Results (MeSH)</term>
<term>Stress Disorders, Post-Traumatic (etiology)</term>
<term>Stress Disorders, Post-Traumatic (psychology)</term>
<term>Stress Disorders, Post-Traumatic (therapy)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Stress Disorders, Post-Traumatic</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Implosive Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Adult Survivors of Child Abuse</term>
<term>Stress Disorders, Post-Traumatic</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Stress Disorders, Post-Traumatic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Psychiatric Status Rating Scales</term>
<term>Quality of Life</term>
<term>Reproducibility of Results</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b>
</p>
<p>Childhood abuse related posttraumatic stress disorder (CA-PTSD) is associated with a high burden of disease and with treatment response rates that leave room for improvement. One of the treatments for PTSD, prolonged exposure (PE), is effective but has high drop-out rates and remission rates are relatively low. An intensified form of PE (iPE) was associated with good response and low drop-out rates in PTSD and has not yet been tested in a controlled trial in CA-PTSD. Phase-based treatment (PBT), in which PE is preceded by skills training may improve overall outcomes in this population. We will assess the effectiveness and cost-effectiveness of standard PE, iPE and PBT in patients with CA-PTSD.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS/DESIGN</b>
</p>
<p>Multi-center randomized controlled trial. Treatment conditions are: prolonged exposure (PE; maximum of 16 sessions in 16 weeks); intensified PE (iPE; maximum of 12 sessions in four weeks and two booster sessions); phase-based treatment (PBT; maximum of eight sessions skills training followed by eight sessions PE in 16 weeks).</p>
</div>
<div type="abstract" xml:lang="en"><p><b>PRIMARY OUTCOME</b>
</p>
<p>Clinician-rated PTSD symptom severity.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>SECONDARY OUTCOMES</b>
</p>
<p>loss of PTSD diagnosis, self-reported PTSD symptom severity, comorbid symptom severity and quality of life. Moreover, we will examine cost-effectiveness and moderators and mediators of treatment outcome.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>TARGET POPULATION</b>
</p>
<p>adults with CA-PTSD (N = 150). Assessments in weeks 0, 4, 8, 16, 26 and 52.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>DISCUSSION</b>
</p>
<p>Given that no consensus yet exists about the treatment guidelines for patients with CA-PTSD, the present study may have important implications for the treatment of CA-PTSD.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>TRAIL REGISTRATION</b>
</p>
<p>Registered at C.C.M.O. on Sept 7, 2016 (NL57984.058.16); retrospectively registered at June 21, 2017 at clinicaltrials.gov identifier: NCT03194113 .</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30541492</PMID>
<DateCompleted><Year>2019</Year>
<Month>09</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-244X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>18</Volume>
<Issue>1</Issue>
<PubDate><Year>2018</Year>
<Month>12</Month>
<Day>12</Day>
</PubDate>
</JournalIssue>
<Title>BMC psychiatry</Title>
<ISOAbbreviation>BMC Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.</ArticleTitle>
<Pagination><MedlinePgn>385</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12888-018-1967-5</ELocationID>
<Abstract><AbstractText Label="BACKGROUND">Childhood abuse related posttraumatic stress disorder (CA-PTSD) is associated with a high burden of disease and with treatment response rates that leave room for improvement. One of the treatments for PTSD, prolonged exposure (PE), is effective but has high drop-out rates and remission rates are relatively low. An intensified form of PE (iPE) was associated with good response and low drop-out rates in PTSD and has not yet been tested in a controlled trial in CA-PTSD. Phase-based treatment (PBT), in which PE is preceded by skills training may improve overall outcomes in this population. We will assess the effectiveness and cost-effectiveness of standard PE, iPE and PBT in patients with CA-PTSD.</AbstractText>
<AbstractText Label="METHODS/DESIGN">Multi-center randomized controlled trial. Treatment conditions are: prolonged exposure (PE; maximum of 16 sessions in 16 weeks); intensified PE (iPE; maximum of 12 sessions in four weeks and two booster sessions); phase-based treatment (PBT; maximum of eight sessions skills training followed by eight sessions PE in 16 weeks).</AbstractText>
<AbstractText Label="PRIMARY OUTCOME">Clinician-rated PTSD symptom severity.</AbstractText>
<AbstractText Label="SECONDARY OUTCOMES">loss of PTSD diagnosis, self-reported PTSD symptom severity, comorbid symptom severity and quality of life. Moreover, we will examine cost-effectiveness and moderators and mediators of treatment outcome.</AbstractText>
<AbstractText Label="TARGET POPULATION">adults with CA-PTSD (N = 150). Assessments in weeks 0, 4, 8, 16, 26 and 52.</AbstractText>
<AbstractText Label="DISCUSSION">Given that no consensus yet exists about the treatment guidelines for patients with CA-PTSD, the present study may have important implications for the treatment of CA-PTSD.</AbstractText>
<AbstractText Label="TRAIL REGISTRATION">Registered at C.C.M.O. on Sept 7, 2016 (NL57984.058.16); retrospectively registered at June 21, 2017 at clinicaltrials.gov identifier: NCT03194113 .</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oprel</LastName>
<ForeName>D A C</ForeName>
<Initials>DAC</Initials>
<AffiliationInfo><Affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hoeboer</LastName>
<ForeName>C M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo><Affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schoorl</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">0000-0002-6468-3934</Identifier>
<AffiliationInfo><Affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>De Kleine</LastName>
<ForeName>R A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo><Affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wigard</LastName>
<ForeName>I G</ForeName>
<Initials>IG</Initials>
<AffiliationInfo><Affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Clinical Psychology, University of Amsterdam, Overschiestraat 61, 1062, XD, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cloitre</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>National Center for PTSD Dissemination and Training Division, Palo Alto Veterans Affairs Palo Alto Health Care System, 795 Willow Road, Menlo Park, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Van Minnen</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>PSYTREC, Prof. dr. Bronkhorststraat 2, 3723, MB, Bilthoven, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Radboud University, Behavioural Science Institute, Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Van der Does</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
<AffiliationInfo><Affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList><AccessionNumber>NCT03194113</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2018</Year>
<Month>12</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>BMC Psychiatry</MedlineTA>
<NlmUniqueID>100968559</NlmUniqueID>
<ISSNLinking>1471-244X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054523" MajorTopicYN="N">Adult Survivors of Child Abuse</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007171" MajorTopicYN="N">Implosive Therapy</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013313" MajorTopicYN="Y">Stress Disorders, Post-Traumatic</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">CA-PTSD</Keyword>
<Keyword MajorTopicYN="Y">Childhood trauma</Keyword>
<Keyword MajorTopicYN="Y">Intensive treatment</Keyword>
<Keyword MajorTopicYN="Y">Phase-based treatment</Keyword>
<Keyword MajorTopicYN="Y">Posttraumatic stress disorder</Keyword>
<Keyword MajorTopicYN="Y">Prolonged exposure</Keyword>
<Keyword MajorTopicYN="Y">STAIR</Keyword>
<Keyword MajorTopicYN="Y">Trauma focused treatment</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year>
<Month>03</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2018</Year>
<Month>11</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30541492</ArticleId>
<ArticleId IdType="doi">10.1186/s12888-018-1967-5</ArticleId>
<ArticleId IdType="pii">10.1186/s12888-018-1967-5</ArticleId>
<ArticleId IdType="pmc">PMC6291949</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Psychother Res. 2016 Sep;26(5):612-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26169837</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Depress Anxiety. 2016 May;33(5):357-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27115940</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Control Clin Trials. 2002 Oct;23(5):481-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12392862</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Qual Life Outcomes. 2013 Apr 12;11:59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23587015</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Child Abuse Negl. 2003 Feb;27(2):169-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12615092</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychol Assess. 2018 Mar;30(3):383-395</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28493729</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Child Psychol Psychiatry. 2017 Nov;58(11):1229-1238</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29057522</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2009 Jan 3;373(9657):68-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19056114</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Trauma Stress. 2010 Oct;23(5):537-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20839310</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Behav Res Ther. 2017 Nov;98:39-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27865431</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Behav Neurosci. 2015 Dec 24;9:351</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26733837</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9881538</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Gen Psychiatry. 1995 Dec;52(12):1048-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7492257</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Psychol Rev. 2017 Aug;56:106-121</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28734184</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Psychiatr Pract. 2014 Jan;20(1):25-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24419308</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Health Serv Res. 2013 Jun 15;13:217</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23768141</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Psychiatry. 2013 Jun;74(6):e541-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23842024</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Psychiatry. 2014 Mar;171(3):294-304</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24480899</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Psychiatry Rep. 2015 Mar;17(3):549</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25736701</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Biom Biostat. 2013 Jul 5;1(1):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25045756</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Psychiatry. 2005 Feb;162(2):214-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15677582</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Psychiatr Res. 2006 Feb;40(1):1-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16242154</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Psychol Rev. 2014 Dec;34(8):645-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25455628</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tijdschr Gerontol Geriatr. 1992 Aug;23(4):132-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1412616</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pers. 2011 Feb;79(1):2-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21223263</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Psychotraumatol. 2014 Sep 15;5:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25279111</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Behav Res Ther. 2002 Apr;40(4):439-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12002900</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11132119</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Consult Clin Psychol. 2002 Oct;70(5):1067-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12362957</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pers Soc Psychol. 2005 Oct;89(4):623-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16287423</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cogn Emot. 2014 Apr;28(3):433-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24044520</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Care. 2013 Dec;51(12):1114-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24226308</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Trauma Stress. 2015 Dec;28(6):489-98</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26606250</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychother Res. 2002 Mar 1;12(1):79-99</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22471333</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychol Med. 2017 Jun;47(8):1370-1378</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28052776</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2014 Jan 08;9(1):e83875</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24416178</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Psychiatry. 2010 Jun;167(6):640-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20360318</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ment Health Serv Res. 2005 Jun;7(2):89-101</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15974155</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Psychiatry. 2010 Aug;167(8):915-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20595411</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychol Rep. 2001 Dec;89(3):595-606</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11824722</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Child Abuse Negl. 2009 Aug;33(8):518-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19758699</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychol Assess. 2017 Feb;29(2):158-171</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27148789</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nerv Ment Dis. 1986 Dec;174(12):727-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3783140</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Psychotraumatol. 2018 Jan 30;9(1):1425574</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29410776</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Psychol Med Settings. 2013 Mar;20(1):37-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22802144</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Gen Psychiatry. 1999 Jul;56(7):600-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10401504</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Assessment. 2004 Dec;11(4):330-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15486169</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2018 Jan 23;319(4):354-364</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29362795</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Consult Clin Psychol. 2004 Jun;72(3):411-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15279525</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Depress Anxiety. 2016 Mar;33(3):247-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26882293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2001 Aug 11;358(9280):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11513908</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pers Disord. 2003 Dec;17(6):562-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14744081</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Depress Anxiety. 2016 May;33(5):359-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26840244</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2016 Oct 10;11(10):e0161645</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27723815</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biol Psychiatry. 2012 Jun 1;71(11):962-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22480663</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Behav Res Ther. 2006 Jul;44(7):1053-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16169513</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Psychotraumatol. 2018 Feb 06;9(1):1430962</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29441153</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Psychotraumatol. 2014 Oct 14;5:23613</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25563302</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychol Assess. 2006 Mar;18(1):112-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16594820</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Clin Psychol. 1996 Feb;35(1):21-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8673033</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Stat Med. 2014 Jan 30;33(2):219-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23922224</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Trauma Stress. 2005 Oct;18(5):425-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16281240</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Consult Clin Psychol. 2013 Jun;81(3):394-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23339535</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Psychol. 2016 Sep;72(9):933-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27018649</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Med. 2012;9(11):e1001349</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23209385</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Interpers Violence. 2016 Nov;31(18):3063-3079</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25948645</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Psychol Rev. 2015 Jun;38:39-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25795293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Child Abuse Negl. 2009 Oct;33(10):666-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19811826</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/WillowV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000569 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000569 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= WillowV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:30541492 |texte= Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:30541492" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a WillowV1
This area was generated with Dilib version V0.6.37. |